Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 23Rectal Neoplasms 11Colonic Neoplasms 11Pancreatic Neoplasms 9Stomach Neoplasms 8Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 8Cholangiocarcinoma 6Adenocarcinoma 6Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 3Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Recurrence 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Small Bowel Adenocarcinoma 1

Interventions

paricalcitol 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Oxaliplatin × 30 days × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡